Purpose To systematically summarize evidence from multiple systematic reviews (SRs)
examining interventions addressing medication nonadherence and to discern differences in …

Prior studies have reported improvements in population-level risk factor burden and
cardiovascular disease (CVD) outcomes using polypills for CVD risk reduction. However, a …

Polypills have been approved in more than 30 countries, but worldwide experience with and
availability of polypills remain limited, unlike fixed-dose combinations in other diseases such …

Background A significant proportion of cardiovascular disease (CVD) morbidity and mortality
could be prevented via the population-based and cost-effective interventions. A fixed-dose …

Background Medication adherence is generally low and challenging to address because
patient actions control healthcare delivery outside of medical environments. Behavioral …

Introduction The growing number of smartphone health applications available in the app
stores makes these apps a promising tool to help reduce the global problem of non …

Objective To evaluate and compare the effect of interventions for improving adherence to
medications for atherosclerotic cardiovascular disease (ASCVD) secondary prevention …

Background: Along with the rapid growth of the global aging society, the mobile and health
digital market has expanded greatly. Countless mobile medical apps (mmApps) have …

Objective The aim of this study was to determine the effect of polypill-based care on the
achievement of 2016 European Society of Cardiology (ESC) guideline targets for blood …

Abstract Purpose of Review Research and clinical services addressing psychosocial
aspects of coronary heart disease (CHD) typically emphasize individuals, focusing less on …